首页
探索
nav.journalClub
趋势
更多
synapse
⌘+K
语言
简体中文
Induced Pluripotent Stem Cells (iPSCs) as a Regenerative Strategy for Parkinson’s Disease: Opportunities and Challenges | Synapse
March 3, 2026
Induced Pluripotent Stem Cells (iPSCs) as a Regenerative Strategy for Parkinson’s Disease: Opportunities and Challenges
AF
Ahmad Faried Ahmad Faried
Universitas Ahmad Dahlan
RR
Reno Rudiman
AA
Achmad Adam
See all
Key Points
iPSCs may improve dopaminergic neuron regeneration in patients with Parkinson's disease, offering hope for neuronal restoration.
Significant advancements in cell differentiation techniques enhance the potential of iPSCs for therapeutic use.
Assessment includes evaluating safety, efficacy, and challenges in clinical applications of stem cell therapies.
Potential for iPSCs to address neurodegeneration issues, but hurdles remain in translation to clinical practice.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Faried et al. (Fri,) studied this question.
synapsesocial.com/papers/69a75efec6e9836116a2a0ab
https://doi.org/https://doi.org/10.1007/s12013-026-01993-6